Jump to content

Haloprogin: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
corrected IUPAC name
Line 1: Line 1:
{{Redirect|Polik}}
{{Redirect|Polik}}
{{drugbox |
{{drugbox |
| IUPAC_name = 1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene
| IUPAC_name = 1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
| image = Haloprogin.png
| image = Haloprogin.png
| image2 = Haloprogin2.png
| image2 = Haloprogin2.png

Revision as of 10:23, 21 December 2008

Haloprogin
File:Haloprogin2.png
Clinical data
Routes of
administration
Topical
ATC code
Legal status
Legal status
  • Not available in U.S.
Identifiers
  • 1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
CAS Number
PubChem CID
DrugBank
CompTox Dashboard (EPA)
ECHA InfoCard100.011.169 Edit this at Wikidata
Chemical and physical data
FormulaC9H4Cl3IO
Molar mass361.39 g·mol−1
Melting point113.5 °C (236.3 °F)

Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections. It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.

Action

Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over the counter primarily to treat tinea infcections of the skin. The mechanism of action is unknown.[1]

Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[2]

References

  1. ^ "Haloprogin". Drugs@FDA. Food and Drug Administration. Retrieved 2007-02-17. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)
  2. ^ "Haloprogin". DrugBank. University of Alberta. Nov 06, 2006. Retrieved 2007-02-17. {{cite web}}: Check date values in: |date= (help); Cite has empty unknown parameter: |coauthors= (help)